![]() |
市場調查報告書
商品編碼
2044467
寵物護膚市場預測至2034年-按產品類型、寵物品種、成分類型、通路和地區分類的全球分析Pet Skin Care Market Forecasts to 2034 - Global Analysis By Product Type (Shampoos, Conditioners, Sprays, Creams & Ointments, Wipes, Medicated Treatments, and Supplements), Pet Type, Ingredient Type, Distribution Channel, and By Geography |
||||||
根據 Stratistics MRC 預測,全球寵物護膚市場預計到 2026 年將達到 60 億美元,並在預測期內以 11% 的複合年成長率成長,到 2034 年將達到 139 億美元。
寵物護膚產品涵蓋多種配方,旨在維護寵物皮膚和毛髮的健康,並治療各種皮膚問題,例如過敏、感染疾病、乾燥和寄生蟲感染。隨著越來越多的飼主將寵物視為家庭成員,並要求像對待自己一樣呵護寵物的皮膚健康,寵物護膚市場正蓬勃發展。寵物皮膚病發病率的上升,加上可支配收入的增加以及消費者對優質化的偏好,持續推動全球已開發市場和新興市場的擴張。
寵物「擬人化」以及對高階寵物照護投入的增加。
寵物飼主越來越將寵物視為家庭成員,這導致他們在寵物保健產品(包括護膚)上的支出增加。這種觀念的轉變正在改變寵物護理的格局,主人開始主動尋求針對特定皮膚問題的解決方案,例如低過敏性洗髮精、藥膏和營養補充劑。隨著飼主更加關注寵物過度抓癢和除毛等不良徵兆,寵物就診於獸醫皮膚科的次數也增加。在人們越來越願意投資符合人類護膚趨勢的高階配方產品的推動下,製造商正在開發創新產品,這些產品融合了天然成分、必需脂肪酸和舒緩植物萃取物,價格也更高。
獸醫皮膚病治療費用高昂
對於許多飼主來說,需要專業診斷和處方箋的護膚產品仍然價格昂貴,這限制了他們獲得有效治療的機會。獸醫諮詢、皮膚過敏測試和特殊藥物的費用可能很高,尤其是對於需要長期管理的慢性疾病。這種經濟障礙常常導致飼主延遲治療,或依賴可能無法徹底解決根本問題的非處方產品。景氣衰退加劇了這一困境,因為家庭會優先滿足寵物的基本需求,而不是購買昂貴的護膚。對於擁有多隻寵物或飼主在寵物保險覆蓋範圍之外的寵物飼主來說,這種經濟挑戰尤其嚴峻。
對天然有機寵物護膚產品的需求日益成長
製造商正利用「潔淨標示」趨勢,開發不含對羥基苯甲酸酯、硫酸鹽、人工香料和刺激性化學物質的配方。寵物飼主越來越關注成分表,並尋找含有植物來源成分的產品,這些成分以其舒緩和保濕功效而聞名,例如燕麥、蘆薈、椰子油和乳木果油。這種需求也延伸到有機認證和環保包裝,與消費者更廣泛的永續性價值相契合。那些有效突出透明採購、臨床功效測試和獸醫推薦的品牌正在獲得顯著的市場佔有率。天然產品的快速成長鼓勵新參與企業和現有的人類護膚公司推出寵物專用產品線,從而擴大了該品類的產品範圍。
對副作用和產品安全性的擔憂
寵物護膚品引發的皮膚刺激、過敏反應和其他不利事件的報告不斷削弱消費者的信心。成分品質參差不齊、配方不當以及各品牌間缺乏標準化的安全測試,都給本身就患有疾病的脆弱寵物帶來了風險。備受矚目的產品召回事件和社群媒體上的負面評價會迅速損害品牌聲譽,並引發人們對整個品類的質疑。法律規範因地區而異,一些市場對寵物化妝品上市前的核准要求極低。這種安全性的不確定性可能導致謹慎的寵物飼主避免嘗試新的產品類型,而選擇依賴獸醫開立的成熟療法。
新冠疫情為寵物護膚市場的發展創造了前所未有的有利條件,全球寵物飼養量的激增以及飼主與寵物相處時間的增加都推動了這一市場的發展。封鎖措施和遠距辦公的普及使飼主能夠更密切地觀察寵物,從而更早發現皮膚問題並進行積極治療。獸醫遠端照護擴大了皮膚科諮詢的覆蓋範圍,而電子商務管道則使產品能夠直接送達消費者手中,無需前往實體店。家庭生活規律的改變也導致寵物出現與壓力相關的皮膚問題,進而增加了對治療的需求。這些行為改變在很大程度上得以延續,即使在疫情高峰期過後,人們對寵物皮膚健康的關注度仍然保持高漲。
在預測期內,洗髮精產業預計將佔據最大的市場佔有率。
預計在預測期內,洗髮精類別將佔據最大的市場佔有率,因為它是最常用且最容易取得的寵物護膚產品類型,發揮著至關重要的作用。定期洗澡是寵物衛生護理的標準環節,洗髮精已成為各個收入水平的負責任的寵物飼主的必備品。製造商正在開發各種針對特定問題的特效產品,例如用於治療癬的抗真菌製劑、用於治療膿皮病的抗菌產品、用於敏感肌膚的燕麥基產品以及用於治療脂漏性脂漏性皮膚炎的藥用洗髮精。與獸醫治療相比,洗髮精價格相對較低,這促進了其日常使用,而諸如免洗洗髮水和美容級洗髮精等創新產品的不斷湧現,也持續拓展了其使用範圍,並提高了消費者的接受度。
在預測期內,保健品產業預計將呈現最高的複合年成長率。
在預測期內,隨著寵物飼主越來越認知到營養在維持寵物皮膚健康方面的重要作用,營養補充品市場預計將呈現最高的成長率。 ω Omega-3脂肪酸、 Omega-6脂肪酸、維生素E、生物素和初乳作為預防和輔助治療手段,在治療異位性皮膚炎、過度除毛和皮膚乾燥脫屑等皮膚疾病方面越來越受歡迎。這些產品透過解決潛在的發炎過程和營養缺乏問題,補充了外用藥物,因此受到尋求整體解決方案的飼主的青睞。咀嚼錠、粉末和滴劑等口服劑型的便利性,以及獸醫對營養療法的日益重視,正在加速各類寵物對營養補充劑的接受度。
在整個預測期內,北美預計將保持最大的市場佔有率,這得益於全球最高的寵物擁有率、顯著的人性化趨勢以及完善的獸醫皮膚病學基礎設施。美國寵物飼主在高階護膚產品上的投入巨大,這得益於寵物專賣店、獸醫診所和電商平台等成熟的分銷網路。該地區健全的法規結構,包括美國食品藥物管理局(FDA)對寵物藥品的監管,增強了消費者對產品安全性和有效性的信心。總部位於北美的領先製造商持續投資於產品創新和消費者意識提升宣傳活動。寵物過敏的高發生率,尤其是在該地區某些熱門犬種中,進一步推動了對專業護膚解決方案的持續需求。
在預測期內,亞太地區預計將呈現最高的複合年成長率。這主要得益於都市區寵物擁有率的快速成長,以及中國、印度、日本和東南亞國家居民可支配收入的增加。推遲生育的年輕專業轉而投資於寵物,將西方的寵物「人性化」概念引入該地區。電子商務平台的蓬勃發展使得以往零售店難以買到的專業寵物護膚產品得以廣泛普及。熱帶地區潮濕炎熱的氣候條件加劇了皮膚感染疾病和寄生蟲疾病的發生,從而增加了對治療的需求。本土製造商正在開發價格親民且符合當地實際情況的產品,而國際品牌則在拓展其分銷網路。這些因素共同推動了該地區的快速成長。
According to Stratistics MRC, the Global Pet Skin Care Market is accounted for $6.0 billion in 2026 and is expected to reach $13.9 billion by 2034 growing at a CAGR of 11% during the forecast period. Pet skin care products encompass a comprehensive range of formulations designed to maintain healthy skin and coat conditions in companion animals while treating various dermatological issues including allergies, infections, dryness, and parasites. This market has gained significant traction as pet owners increasingly view their animals as family members, demanding the same level of care and attention to skin health that they seek for themselves. The growing prevalence of pet skin conditions, combined with rising disposable incomes and premiumization trends, continues to fuel market expansion across both developed and emerging economies worldwide.
Rising pet humanization and premium care spending
Pet owners are increasingly treating their companion animals as family members, leading to higher spending on specialized health and wellness products including skin care. This emotional shift has transformed the pet care landscape, with owners actively seeking condition-specific solutions such as hypoallergenic shampoos, medicated ointments, and nutritional supplements for skin health. Veterinary dermatology visits are rising as owners become more attentive to signs of discomfort like excessive scratching or hair loss. The willingness to invest in premium formulations, often mirroring human skin care trends, has encouraged manufacturers to develop innovative products with natural ingredients, essential fatty acids, and soothing botanical extracts that command higher price points.
High cost of veterinary dermatological treatments
Professional diagnosis and prescription-strength skin care products remain prohibitively expensive for many pet owners, limiting access to effective treatments. Veterinary consultations, skin allergy testing, and specialized medicated formulations can accumulate substantial costs, particularly for chronic conditions requiring ongoing management. This financial barrier often leads owners to delay treatment or rely on over-the-counter products that may provide incomplete resolution of underlying issues. Economic downturns further exacerbate this restraint as households prioritize essential pet needs over premium skin care. The cost challenge is particularly acute for owners of multiple pets or those living in regions without comprehensive pet insurance coverage.
Growing demand for natural and organic pet skin care
Manufacturers are capitalizing on the clean label movement by developing formulations free from parabens, sulfates, artificial fragrances, and harsh chemicals. Pet owners are increasingly scrutinizing ingredient lists, seeking products with oatmeal, aloe vera, coconut oil, shea butter, and other botanicals known for soothing and moisturizing properties. This demand extends to organic certifications and eco-friendly packaging, aligning with broader consumer values around sustainability. Brands successfully communicating transparent sourcing, clinical efficacy testing, and veterinary endorsements are capturing significant market share. The natural segment's rapid growth is encouraging new entrants and established human skin care companies to launch dedicated pet product lines, expanding category availability.
Adverse reactions and product safety concerns
Reports of skin irritations, allergic reactions, and other adverse events associated with pet skin care products continue to challenge consumer confidence. Inconsistent ingredient quality, incorrect formulation concentrations, and lack of standardized safety testing across different brands create risks for vulnerable animals with pre-existing conditions. High-profile product recalls or negative social media reviews can rapidly damage brand reputation and create category-wide skepticism. Regulatory oversight varies significantly across regions, with some markets having minimal pre-market approval requirements for pet cosmetics. This safety uncertainty may lead cautious pet owners to avoid newer product categories, instead relying on veterinary-prescribed treatments with established safety profiles.
The COVID-19 pandemic created unprecedented conditions for pet skin care market growth, driven by the global surge in pet adoptions and increased owner-pet interaction time. Lockdowns and remote work arrangements allowed owners to observe their pets more closely, leading to earlier detection of skin conditions and proactive treatment seeking. Veterinary telemedicine expanded access to dermatological consultations, while e-commerce channels facilitated direct-to-consumer product delivery without physical store visits. Stress-related skin conditions in pets, triggered by changes in household routines, also increased treatment demand. These behavioral shifts have proven largely durable, with elevated baseline awareness of pet skin health persisting beyond the acute pandemic period.
The Shampoos segment is expected to be the largest during the forecast period
The Shampoos segment is expected to account for the largest market share during the forecast period, driven by their essential role as the most frequently used and accessible pet skin care product category. Regular bathing is a standard component of pet hygiene routines, making shampoos a recurring purchase for responsible pet owners across all income levels. Manufacturers have developed extensive specialized variants targeting specific conditions including antifungal formulations for ringworm, antibacterial options for pyoderma, oatmeal-based products for sensitive skin, and medicated shampoos for seborrhea. The relatively affordable price point compared to veterinary treatments encourages routine use, while innovations in waterless and grooming-quality shampoos continue expanding usage occasions and consumer adoption.
The Supplements segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the Supplements segment is predicted to witness the highest growth rate as pet owners increasingly recognize the role of nutrition in maintaining healthy skin from within. Omega-3 fatty acids, omega-6 fatty acids, vitamin E, biotin, and colostrum are gaining popularity as proactive and adjunctive approaches to managing skin conditions including atopic dermatitis, excessive shedding, and dry flaky skin. These products complement topical treatments by addressing underlying inflammatory processes and nutritional deficiencies, appealing to owners seeking holistic solutions. The convenience of oral administration through chews, powders, or drops, combined with growing veterinary recommendation of nutritional interventions, is accelerating supplement adoption across all pet types.
During the forecast period, the North America region is expected to hold the largest market share, supported by the highest pet ownership rates globally, strong humanization trends, and advanced veterinary dermatology infrastructure. United States pet owners spend significantly on premium skin care products, with established distribution through pet specialty retailers, veterinary clinics, and e-commerce platforms. The region's robust regulatory framework, including FDA oversight of medicated pet products, builds consumer confidence in safety and efficacy claims. Major manufacturers headquartered in North America continue investing in product innovation and consumer education campaigns. The high prevalence of pet allergies, particularly in certain dog breeds popular in the region, further drives sustained demand for specialized skin care solutions.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fueled by rapidly rising pet ownership rates in urban centers and increasing disposable incomes across China, India, Japan, and Southeast Asian nations. Young professionals delaying parenthood are instead investing in companion animals, bringing Western-style pet humanization trends to the region. E-commerce platforms have democratized access to specialized pet skin care products previously unavailable through traditional retail channels. Climate conditions including humidity and heat in tropical areas contribute to higher prevalence of skin infections and parasite issues, increasing treatment demand. Local manufacturers are developing regionally affordable products while international brands expand distribution, collectively driving the fastest regional growth.
Key players in the market
Some of the key players in Pet Skin Care Market include Zoetis Inc., Boehringer Ingelheim International GmbH, Virbac SA, Dechra Pharmaceuticals PLC, Vetoquinol SA, Ceva Sante Animale, Elanco Animal Health Incorporated, PetIQ, Inc., Hartz Mountain Corporation, Bayer AG, Nestle Purina PetCare Company, Hill's Pet Nutrition, Inc., Royal Canin SAS, Beaphar B.V., TropiClean Pet Products, Earthbath Corporation, and SynergyLabs.
In February 2026, PetIQ launched its "Hardworking Pets" campaign for the PetArmor brand, focusing on affordable, over-the-counter flea, tick, and skin parasite protection for budget-conscious consumers.
In February 2026, the FDA granted Emergency Use Authorization (EUA) for NexGard(R) (afoxolaner) and NexGard(R) COMBO to treat New World screwworm infestations in dogs and cats. The company emphasized that routine flea and tick control is a critical component of skin health, as it minimizes the irritation and wounds that lead to secondary infections.
In February 2026, Elanco Animal Health Incorporated received USDA approval for Befrena(TM), a new anti-IL31 monoclonal antibody injection for canine allergic and atopic dermatitis. It differentiates itself with a longer 6-to-8-week dosing interval compared to current market competitors.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.